A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Epigenetic Regulation of BDNF in Major Depression
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Creatine Augmentation in Veterans With SSRI-Resistant Major Depression
- Status
- WITHDRAWN
- Phase
- PHASE4
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study
- Status
- TERMINATED
- Phase
- NA
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE4
The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse
- Status
- COMPLETED
- Phase
- PHASE3
6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder
- Status
- TERMINATED
- Phase
- PHASE2
Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
- Status
- COMPLETED
- Phase
- PHASE4
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)
- Status
- COMPLETED
- Phase
- PHASE4
NeuroStar TMS Therapy System: Utilization and Outcomes
- Status
- COMPLETED
- Phase
- N/A